Browse > Article
http://dx.doi.org/10.17946/JRST.2021.44.3.239

1H-NMR Analysis according to the Storage Period after the Use of Iopamidol and Ioversol Formulations Contrast Agents  

Han, Beom-Hee (R&D Team of Radiation Science Technology Laboratory)
Publication Information
Journal of radiological science and technology / v.44, no.3, 2021 , pp. 239-245 More about this Journal
Abstract
Since the side effects of contrast agents occur in many ways, hospitals must clearly identify the contrast agents and know how to manage them. Storage of contrast media It is common practice to store contrast media in a warm room to reduce viscosity and improve patient comfort. However, it is important to recognize that long-term storage at high temperatures can shorten the shelf life of a product. Therefore, in this study, the presence or absence of chemical changes according to the storage period after using the contrast medium was analyzed. As the analysis equipment, a 500 MHz Nuclear Magnetic Resonance Spectrometer of Bruker Avance (Germany) possessed by Korea Basic Science Institute (KOREA BASIC SCIENCE INSTITUTE; KBSI) was used. For the X-ray iodide contrast medium, Pamiray contrast medium of Iopamidol and Optiray contrast medium of Ioversol, samples remaining after 7 days, 20 days, 30 days, and 1 year were collected, By acquiring the spectrum from the 1H-NMR spectrometer of the contrast medium stimulated by It was compared and analyzed with the standard sample. In conclusion, depending on the storage period of the contrast medium, no peaks of physical and chemical changes were observed in both the Pamiray contrast medium of Iopamidol and the Optiray contrast medium of Ioversol after 7 days, 20 days, 30 days, and 1 year after use.
Keywords
Contrast Agents; Iopamidol; Ioversol; NMR; Storage Period;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Evill CA, Wilson Al, Sage MR. Chemotoxic effects of low-osmolar contrast media on the blood brain barrier. Invest Radiol. 1990;25:S82-3.   DOI
2 Penry JB, Livingstone JB. A comparison of diagnostic effectiveness and vascular side-effects of various diatrizoate salts used for intravenous pyelography. Clin Radiol. 1972;23:362-9.   DOI
3 Dawson P, David O, Ronald G. Textbook Contrast Media. British Library; 1999.
4 Lee SK. The analysis of NMR spectrum. Hanrimwon; 2014.
5 Sidhu PS, Dawson P. Guidelines for the management of reactions to intravenous contrast media. London: Royal College of Radiologists; 1993.
6 Han BH. Physicochemical analysis according to temperature changes of iopamidol and ioversol formulation. Journal of Radiological Science and Technology. 2020;43(4);273-80.   DOI
7 Dongkook Life Science. 2017; from: http://www.dkls.co.kr/product/view.php?type=medicine&idx=21.
8 Sistrom CL, Gay SB, Peffley RN. Extravasation of iopamidol and iohexol during contrast-enhanced CT: A report of 28 cases. Radiology. 1991;180: 707-10.   DOI
9 Cardinal HN, Holdsworth DW, Drangova M, et al. Experimental and theoretical X-ray imaging performance comparison of iodine and lanthanide contrast agents. Med Phys. 1993;20:15-31.   DOI
10 Yu SM, Han DK, Hong JW. Comparative analysis of death-related iodide contrast media due to adverse reactions of contrast media in computed tomography. Journal of Radiological Science and Technology. 2021;44(1):47-52.   DOI
11 Blum W, Weinberg U, Shenkman L, et al. Hyperthy-roidism after iodinated contrast medium. N Engl J Med. 1974;291:24-5.   DOI
12 Wang CL, Cohan RH, Ellis JH, et al. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR. 2008;191(2):409-15.   DOI
13 Thrall JH. Adverse reactions to contrast media. In: Swan-son DP, Chilton HM, Thrall JH(eds) Pharmaceuticals in medical imaging. 1st ed. New York: Macmillan; 1990:253-77.
14 Cohan RH, Ellis JH, Garner WL. Extravasation of radiographic contrast material: Recognition, prevention, and treatment. Radiology. 1996;200: 593-604.   DOI
15 Kim MC, Kim KK, Kweon DC, Lim CH, Kim HJ, Im IC, et al. Textbook of computed tomography. Chung Ku Publisher; 2020.
16 Kang YH. The Precaution duty and the product liability for adverse reactions to the contrast media. Journal of Radiological Science and Technology. 2007:30(4):305-11.
17 Kwon KS. Anlaysis of Adverse Reactions to CT contrast Medium. University of Ulsan; 2004.
18 Kim SH, Park JH, Kim YL, et al. Experimental tissue damage after subcutaneous injection of water soluble contrast media. Invest Radiol. 1990;25:678-85.   DOI